Kanad Labs Private Limited - pharma in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH2002PTC138026 Incorporated 28 November 2002 ROC Mumbai HQ Nagpur, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹8.63 Cr
▲ 6% YoY
Net profit · FY 2025
₹11.24 Lakh
Net margin 1.3%
EBITDA · FY 2025
₹25.61 Lakh
EBITDA margin 3%
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹40 Lakh
Issued & subscribed
Open charges
₹1.84 Cr
Secured borrowings
Company age
24 yrs
Est. 2002
Employees · EPFO
44
Provident fund records

About Kanad Labs Private Limited

Data last updated:

Kanad Labs Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 November 2002 and has been in existence for over 24 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2002PTC138026. Its GSTIN is 27AACCK2461L1ZE (Maharashtra).

The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors including Girish Sharad Borale and Ajay Prabhakar Patinge.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nagpur, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹8.63 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹11.24 Lakh (net margin 1.3%) and EBITDA of ₹25.61 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 8% over five years.

The company has about 44 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Kanad Labs. As per MCA filings, the company has open charges of ₹1.84 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kanadlabs.com.

Company Details of Kanad Labs Private Limited
CIN U24230MH2002PTC138026
Registration Number 138026
Incorporation Date 28 November 2002
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Plot No. R – 4 Kamal Nagar, Amraoti Rd Wadi, Nagpur, Maharashtra, India – 440026
  • Industry
    Pharma, Drug Formulation & Development, Pharmaceutical Retailers & Distributors
Comprehensive company report
Kanad Labs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Kanad Labs Private Limited report

Financials, compliance, directors, charges, ownership and filings for Kanad Labs Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Kanad Labs Private Limited

The main business activity of Kanad Labs is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GWholesale and retail trade; repair of motor vehicles and motorcycles45Wholesale and retail trade and repair of motor vehicles and motorcyclesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Kanad Labs Private Limited FY 2025 filings available

Kanad Labs Private Limited reported revenue of ₹8.63 Cr (up 6% YoY) for FY 2025.

Revenue · FY 2025
₹8.63 Cr ▲ 6%
Net profit · FY 2025
₹11.24 Lakh margin 1.3%
EBITDA · FY 2025
₹25.61 Lakh margin 3%

Compounded Annual Growth Rate (CAGR) of Kanad Labs Private Limited

Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 10%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 27%
5 years · compounded
▲ 1%

Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 6% growth in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Kanad Labs Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹25.61 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹11.24 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Kanad Labs Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3%••••••••••••••••
Net Profit Margin1.3%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kanad Labs are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Kanad Labs Private Limited

Kanad Labs Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Waxsen Lifescience Private Limited₹8.64 Cr (FY 2019)••••••••-50.0%••••Mumbai, Maharashtra, India
Prajna Generics Private Limited₹8.64 Cr (FY 2022)••••••••3.0%••••Quthubullapur Mandal, Telangana, India
MSK Pharmaceuticals Private Limited₹8.64 Cr (FY 2025)••••••••55.0%••••Saraipali, Chattisgarh, India
Apogen Remedies Private Limited₹8.63 Cr (FY 2025)••••••••-35.0%••••Siddipet, Telangana, India
Nansika Enterprises Private Limited₹8.63 Cr (FY 2025)••••••••2148.0%••••New Delhi, Delhi, India
Kanad Labs Private Limited this company₹8.63 Cr (FY 2025)••••••••6.0%••••Nagpur, Maharashtra, India
Urihk Pharmaceutical Private Limited₹8.62 Cr (FY 2025)••••••••-19.0%••••Mumbai, Maharashtra, India
Sadanjana Pharma Private Limited₹8.61 Cr (FY 2024)••••••••70.0%••••Hyderabad, Telangana, India
Srikar Chem & Pharma India Private Limited₹8.6 Cr (FY 2024)••••••••-11.0%••••Hyderabad, Telangana, India
Zahidi Pharmaceuticals Private Limited₹8.6 Cr (FY 2025)••••••••2.0%••••Umbergaon, Gujarat, India
Kaizen Research Labs India Private Limited₹8.6 Cr (FY 2025)••••••••-17.0%••••Chennai, Tamil Nadu, India

Peers are the five companies nearest above and the five nearest below Kanad Labs by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Kanad Labs Private Limited

Kanad Labs Private Limited is audited by SHRIDHAR DESAI AND ASSOCIATES for the financial year 2023.

NameStatusAppointment DateCessation Date
SHRIDHAR DESAI AND ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Kanad Labs Private Limited

Kanad Labs has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Girish Sharad BoraleDirector28 Nov 200223 Years 10 MonthsCurrent
Ajay Prabhakar PatingeDirector02 Dec 200322 Years 10 MonthsCurrent
Girish Bhalchandra WaranashiwarDirector13 Jan 200719 Years 8 MonthsCurrent

Ownership and Shareholding of Kanad Labs Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Kanad Labs Private Limited

Open charges
₹1.84 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹1.08 Cr
Icici Bank Limited₹0.44 Cr
Hdfc Bank Limited₹0.32 Cr
Latest charge details
DateLenderAmountStatus
24 Aug 2022Hdfc Bank Limited₹7.19 LakhOpen
25 May 2022Hdfc Bank Limited₹12.49 LakhOpen
04 May 2022Hdfc Bank Limited₹12.49 LakhOpen
26 May 2016Others₹7.8 LakhOpen
16 May 2014Icici Bank Limited₹43.75 LakhOpen

Total charge records: 6 View all charges

MSME Payment Delays by Kanad Labs Private Limited

Kanad Labs Private Limited has 2 MSME Form 1 returns on record between 2019 and 2021, listing 18 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 14)

SupplierAmount dueDue sinceReported on
Jips Pharmaceuticals Private Limited••••••••••••
Perennial Medicare••••••••••••
an individual supplier••••••••••••
Unimarck Healthcare Limited••••••••••••
Asoj Soft Caps Pvt Ltd••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Associated Brands with Kanad Labs Private Limited

Kanad Labs operates one associated brand: Kanad Labs. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical manufacturing and health services focused on quality and cost effectiveness in India.kanadlabs.com

Employees and EPFO Compliance at Kanad Labs Private Limited

Kanad Labs Private Limited has a workforce of 44 employees as of Apr 06, 2024.

Employee count
44
Active EPFO establishments
1
Employee growth
18.92%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Kanad Labs Private Limited

Kanad Labs Private Limited has 3 board changes on record since 2002: 3 appointments. The latest: Girish Bhalchandra Waranashiwar was appointed as Director on 13 Jan 2007.

AGM
Kanad Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Kanad Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.19 Lakh with Charge ID 100613636 was registered on 24 Aug 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 12.49 Lakh with Charge ID 100600255 was registered on 25 May 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 12.49 Lakh with Charge ID 100598097 was registered on 04 May 2022.
Charges
A charge with Others of Rs. 100.00 Lakh registered on 29 Apr 2011 with Charge ID 10292647 was modified on 23 Apr 2018.
Charges
A charge with Others amounted to Rs. 7.80 Lakh with Charge ID 100030688 was registered on 26 May 2016.
Charges
A charge with Icici Bank Limited amounted to Rs. 43.75 Lakh with Charge ID 10489344 was registered on 16 May 2014.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 10292647 was registered on 29 Apr 2011.
Appointed
Girish Bhalchandra Waranashiwar was appointed as Director.
Appointed
Ajay Prabhakar Patinge was appointed as Director.
Appointed
Girish Sharad Borale was appointed as Director.

1 earlier event is listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Kanad Labs Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Kanad Labs Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Kanad Labs Private Limited

Kanad Labs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AACCK2461L1ZEMaharashtraActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Kanad Labs Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanad Labs Private Limited

Kanad Labs is an active private limited company based in Nagpur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 November 2002 (24+ years old) and is registered under CIN U24230MH2002PTC138026.

Kanad Labs reported revenue of ₹8.63 Cr for FY 2025 (up 6% YoY).

Kanad Labs has 3 current directors:

Kanad Labs reported a net profit of ₹11.24 Lakh (net margin 1.3%) and EBITDA of ₹25.61 Lakh (EBITDA margin 3%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Kanad Labs is 10% over three years and 8% over five years. In the latest year (FY 2025) revenue rose 6%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Kanad Labs is 27AACCK2461L1ZE, registered in Maharashtra.

The CIN (Corporate Identification Number) of Kanad Labs is U24230MH2002PTC138026. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Kanad Labs has 1 court case on record: 1 filed by the company. 1 is pending.

Kanad Labs was incorporated on 28 November 2002, making it 24+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Kanad Labs by revenue are Waxsen Lifescience Private Limited, Prajna Generics Private Limited, MSK Pharmaceuticals Private Limited, Apogen Remedies Private Limited, Nansika Enterprises Private Limited and 5 more, all in the Pharma industry (Formulations, Pharma Retail and Distribution).

Girish Bhalchandra Waranashiwar was appointed as Director on 13 Jan 2007. Ajay Prabhakar Patinge was appointed as Director on 02 Dec 2003. Girish Sharad Borale was appointed as Director on 28 Nov 2002.

Kanad Labs has 2 MSME Form 1 returns on record between 2019 and 2021, listing 18 overdue payments to 14 micro and small suppliers. The latest return was filed on 20 Apr 2021.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available